Aimmune’s Palforzia gets FDA approval for treatment of peanut allergyPharmaceutical Business ReviewFri, July 27th - 12:14 AM 2018
Takeda’s ALUNBRIG gets FDA priority review for expanded indication in NSCLCPharmaceutical Business ReviewSat, February 29th - 7:12 PM 2020
Novartis, DNDi to jointly develop LXE408 for visceral leishmaniasisPharmaceutical Business ReviewSat, February 29th - 7:12 PM 2020
Lysogene receives FDA fast track designation for LYS-SAF302 gene therapy in MPS IIIAPharmaceutical Business ReviewSat, February 29th - 7:12 PM 2020
FDA approves GSK’s Advil Dual Action with Acetaminophen OTC pain relieverPharmaceutical Business ReviewTue, March 3rd - 7:14 PM 2020
Takeda completes sale of select OTC and non-core assets to AcinoPharmaceutical Business ReviewTue, March 3rd - 7:14 PM 2020
Iktos, SRI join forces for AI-driven drug discovery to combat COVID-19 and other virusesPharmaceutical Business ReviewWed, March 4th - 7:12 PM 2020
FDA approves new treatment for paediatric patients with any strain of Hepatitis CPharmaceutical Business ReviewFri, March 20th - 8:10 PM 2020
Amneal accelerates distribution and production of Hydroxychloroquine Sulfate to meet potential needs of COVID-19 patients nationwidePharmaceutical Business ReviewMon, March 23rd - 8:08 PM 2020
ViiV Healthcare secures Canadian approval for HIV drug regimen CABENUVAPharmaceutical Business ReviewMon, March 23rd - 8:08 PM 2020

Pages